151 related articles for article (PubMed ID: 38695202)
1. Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols.
Redfors B
Scand Cardiovasc J; 2024 Dec; 58(1):2343383. PubMed ID: 38695202
[No Abstract] [Full Text] [Related]
2. Advancing Value-Based Cardiovascular Care: The American Heart Association Value in Healthcare Initiative.
McClellan MB; Bleser WK; Joynt Maddox KE
Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006610. PubMed ID: 32393127
[No Abstract] [Full Text] [Related]
3. Use of Chronic Disease Registries to Optimize Cardiovascular Health.
Gosavi S; Bhagavat A
Curr Vasc Pharmacol; 2016; 14(5):426-431. PubMed ID: 27456106
[TBL] [Abstract][Full Text] [Related]
4. Value in Healthcare Special Issue.
Ho PM
Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006817. PubMed ID: 32393126
[No Abstract] [Full Text] [Related]
5. Numbers needed to treat (lives!) and numbers needed to save (money).
Ribichini F; Taggart D; Vassanelli C
EuroIntervention; 2013 Jun; 9(2):175-7. PubMed ID: 23793004
[No Abstract] [Full Text] [Related]
6. Do cardiology quality measures actually improve patient outcomes?
Chatterjee P; Joynt KE
J Am Heart Assoc; 2014 Feb; 3(1):e000404. PubMed ID: 24510114
[No Abstract] [Full Text] [Related]
7. The Institute of Medicine committee report "best care at lower cost: the path to continuously learning health care".
Ferguson TB
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):e93-4. PubMed ID: 23170008
[No Abstract] [Full Text] [Related]
8. Imaging Registries and Single-Center Series.
Hachamovitch R; Peña JM; Xie J; Shaw LJ; Min JK
JACC Cardiovasc Imaging; 2017 Mar; 10(3):276-285. PubMed ID: 28279375
[TBL] [Abstract][Full Text] [Related]
9. Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?
Ara R; Hill H; Lloyd A; Woods HB; Brazier J
Value Health; 2020 Mar; 23(3):397-405. PubMed ID: 32197736
[TBL] [Abstract][Full Text] [Related]
10. "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.
Bailly L; Mossé P; Diagana S; Fournier M; d'Arripe-Longueville F; Diagana O; Gal J; Grebet J; Moncada M; Domerego JJ; Radel R; Fabre R; Fuch A; Pradier C
BMC Cardiovasc Disord; 2018 Dec; 18(1):225. PubMed ID: 30522438
[TBL] [Abstract][Full Text] [Related]
11. Most important papers in health costs, cost-effectiveness, and resource utilization.
Dharmarajan K; Lampropulos J; Bikdeli B; Mody P; Gupta A
Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):e9-15. PubMed ID: 22438466
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of model-based analyses reporting the cost-effectiveness and cost-utility of cardiovascular disease management programs.
Maru S; Byrnes J; Whitty JA; Carrington MJ; Stewart S; Scuffham PA
Eur J Cardiovasc Nurs; 2015 Feb; 14(1):26-33. PubMed ID: 24836972
[TBL] [Abstract][Full Text] [Related]
13. Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?
Otero HJ; Rybicki FJ; Greenberg D; Mitsouras D; Mendoza JA; Neumann PJ
Int J Cardiovasc Imaging; 2010 Aug; 26(6):605-12. PubMed ID: 20446040
[TBL] [Abstract][Full Text] [Related]
14. The economics of cardiovascular disease in the United States.
Chen J; Rizzo JA
Crit Care Clin; 2012 Jan; 28(1):77-88, vi. PubMed ID: 22123100
[TBL] [Abstract][Full Text] [Related]
15. Risk Avoidance: For Whom?
King SB
JACC Cardiovasc Interv; 2016 Jan; 9(1):110-111. PubMed ID: 26762924
[No Abstract] [Full Text] [Related]
16. How to develop cost-conscious guidelines.
Eccles M; Mason J
Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.
Huang Y; Kypridemos C; Liu J; Lee Y; Pearson-Stuttard J; Collins B; Bandosz P; Capewell S; Whitsel L; Wilde P; Mozaffarian D; O'Flaherty M; Micha R;
Circulation; 2019 Jun; 139(23):2613-2624. PubMed ID: 30982338
[TBL] [Abstract][Full Text] [Related]
18. Value-Based Payment Reforms in Cardiovascular Care: Progress to Date and Next Steps.
Sukul D; Eagle KA
Methodist Debakey Cardiovasc J; 2020; 16(3):232-240. PubMed ID: 33133360
[TBL] [Abstract][Full Text] [Related]
19. Cost and benefit in cardiovascular imaging: the quest for economic sustainability.
Leo CG; Carpeggiani C; Picano E
Int J Cardiovasc Imaging; 2010 Aug; 26(6):613-6. PubMed ID: 20437104
[No Abstract] [Full Text] [Related]
20. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
